Table 2.
Immunophenotyping data of P1 at age 35
ParameterResult
ANC 400 (↓) 
AMC 600 
ALC 600 
CD3 420 (70%; ↓) 
CD4 288 (48%; ↓) 
CD8 104 (17.4%; ↓) 
CD4/CD45RA 54 (9%; ↓) 
CD4/CD45RO 16 (2.6%; ↓) 
CD19 7 (1.2%; ↓) 
CD19/CD27 6 (1%; ↓) 
CD3+/CD56+ 25 (4.1%) 
CD3/CD56+ 109.2 (18.2%) 
ParameterResult
ANC 400 (↓) 
AMC 600 
ALC 600 
CD3 420 (70%; ↓) 
CD4 288 (48%; ↓) 
CD8 104 (17.4%; ↓) 
CD4/CD45RA 54 (9%; ↓) 
CD4/CD45RO 16 (2.6%; ↓) 
CD19 7 (1.2%; ↓) 
CD19/CD27 6 (1%; ↓) 
CD3+/CD56+ 25 (4.1%) 
CD3/CD56+ 109.2 (18.2%) 

Because the measurements were performed in various clinical laboratories, ↓ indicates that at least one of the measurements during this time was lower than the reference range of the corresponding laboratory. ↑ indicates that at least one measurement was higher than the controls. ANC, absolute neutrophil count; AMC, absolute monocyte count (as evaluated by automated or manual differential count); ALC, absolute lymphocyte count.

or Create an Account

Close Modal
Close Modal